Ken Takanashi - Net Worth and Insider Trading
Ken Takanashi Net Worth
The estimated net worth of Ken Takanashi is at least $44 Million dollars as of 2024-10-09. Ken Takanashi is the Director, 10% Owner of Satsuma Pharmaceuticals Inc and owns about 24,847,694 shares of Satsuma Pharmaceuticals Inc (STSA) stock worth over $27 Million. Ken Takanashi is also the Director, 10% Owner of WAVE Life Sciences Ltd and owns about 1,984,130 shares of WAVE Life Sciences Ltd (WVE) stock worth over $17 Million. Details can be seen in Ken Takanashi's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ken Takanashi has not made any transactions after 2023-06-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Ken Takanashi
Ken Takanashi Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ken Takanashi owns 2 companies in total, including WAVE Life Sciences Ltd (WVE) , and Satsuma Pharmaceuticals Inc (STSA) .
Click here to see the complete history of Ken Takanashi’s form 4 insider trades.
Insider Ownership Summary of Ken Takanashi
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| WVE | WAVE Life Sciences Ltd | 2015-11-16 | director & 10 percent owner |
| STSA | Satsuma Pharmaceuticals Inc | 2023-06-06 | director & 10 percent owner |
Ken Takanashi Latest Holdings Summary
Ken Takanashi currently owns a total of 2 stocks. Among these stocks, Ken Takanashi owns 24,847,694 shares of Satsuma Pharmaceuticals Inc (STSA) as of June 6, 2023, with a value of $27 Million and a weighting of 62.09%. Ken Takanashi also owns 1,984,130 shares of WAVE Life Sciences Ltd (WVE) as of November 16, 2015, with a value of $17 Million and a weighting of 37.91%.
Latest Holdings of Ken Takanashi
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| STSA | Satsuma Pharmaceuticals Inc | 2023-06-06 | 24,847,694 | 1.10 | 27,332,463 |
| WVE | WAVE Life Sciences Ltd | 2015-11-16 | 1,984,130 | 8.41 | 16,686,533 |
Holding Weightings of Ken Takanashi
Ken Takanashi Form 4 Trading Tracker
According to the SEC Form 4 filings, Ken Takanashi has made a total of 1 transactions in Satsuma Pharmaceuticals Inc (STSA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Satsuma Pharmaceuticals Inc is the acquisition of 22,053,581 shares on June 6, 2023, which cost Ken Takanashi around $20 Million.
According to the SEC Form 4 filings, Ken Takanashi has made a total of 0 transactions in WAVE Life Sciences Ltd (WVE) over the past 5 years. The most-recent trade in WAVE Life Sciences Ltd is the acquisition of 125,000 shares on November 16, 2015, which cost Ken Takanashi around $2 Million.
Insider Trading History of Ken Takanashi
- 1
Ken Takanashi Trading Performance
GuruFocus tracks the stock performance after each of Ken Takanashi's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ken Takanashi is -21.85%. GuruFocus also compares Ken Takanashi's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ken Takanashi within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Ken Takanashi's insider trading performs compared to the benchmark.
Performance of Ken Takanashi
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -26.82 | | | | | |
| Relative Return to S&P 500(%) | -27.18 | | | | | |
Ken Takanashi Ownership Network
Ken Takanashi Owned Company Details
What does WAVE Life Sciences Ltd do?
Who are the key executives at WAVE Life Sciences Ltd?
Ken Takanashi is the director & 10 percent owner of WAVE Life Sciences Ltd. Other key executives at WAVE Life Sciences Ltd include 10 percent owner Plc Glaxosmithkline , See Remarks Kyle Moran , and director & See Remarks Paul Bolno .
WAVE Life Sciences Ltd (WVE) Insider Trades Summary
Over the past 18 months, Ken Takanashi made no insider transaction in WAVE Life Sciences Ltd (WVE). Other recent insider transactions involving WAVE Life Sciences Ltd (WVE) include a net sale of 69,838 shares made by Kyle Moran , a net purchase of 6,091,930 shares made by Plc Glaxosmithkline , and a net purchase of 2,000,000 shares made by Ra Capital Healthcare Fund Lp .
In summary, during the past 3 months, insiders sold 65,512 shares of WAVE Life Sciences Ltd (WVE) in total and bought 2,791,930 shares, with a net purchase of 2,726,418 shares. During the past 18 months, 118,204 shares of WAVE Life Sciences Ltd (WVE) were sold and 8,091,930 shares were bought by its insiders, resulting in a net purchase of 7,973,726 shares.
WAVE Life Sciences Ltd (WVE)'s detailed insider trading history can be found in Insider Trading Tracker table.
WAVE Life Sciences Ltd Insider Transactions
Ken Takanashi Mailing Address
Above is the net worth, insider trading, and ownership report for Ken Takanashi. You might contact Ken Takanashi via mailing address: C/o Wave Life Sciences Ltd., 733 Concord Ave., Cambridge Ma 02138.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
